Global Hepatitis Drugs Market Insights and Forecast to 2026

Global Hepatitis Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Hepatitis Drugs Product Introduction
1.2 Market Segments
1.3 Key Hepatitis Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hepatitis Drugs Market Size Growth Rate by Type
1.4.2 VEMLIDY
1.4.3 EPCLUSA
1.4.4 SOVALDI
1.4.5 INCIVEK
1.4.6 OLYSIO
1.4.7 VICTRELIS
1.4.8 VIREAD
1.4.9 HEPSERA
1.4.10 BARACLUDE
1.4.11 TYZEKA
1.5 Market by Application
1.5.1 Global Hepatitis Drugs Market Size Growth Rate by Application
1.5.2 Hepatitis A
1.5.3 Hepatitis B
1.5.4 Hepatitis C
1.5.5 Hepatitis D
1.5.6 Hepatitis E
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hepatitis Drugs Market Size, Estimates and Forecasts
2.1.1 Global Hepatitis Drugs Revenue 2015-2026
2.1.2 Global Hepatitis Drugs Sales 2015-2026
2.2 Global Hepatitis Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hepatitis Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hepatitis Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hepatitis Drugs Competitor Landscape by Players
3.1 Hepatitis Drugs Sales by Manufacturers
3.1.1 Hepatitis Drugs Sales by Manufacturers (2015-2020)
3.1.2 Hepatitis Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Hepatitis Drugs Revenue by Manufacturers
3.2.1 Hepatitis Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Hepatitis Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hepatitis Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hepatitis Drugs Revenue in 2019
3.2.5 Global Hepatitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hepatitis Drugs Price by Manufacturers
3.4 Hepatitis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Hepatitis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hepatitis Drugs Market Size by Type (2015-2020)
4.1.1 Global Hepatitis Drugs Sales by Type (2015-2020)
4.1.2 Global Hepatitis Drugs Revenue by Type (2015-2020)
4.1.3 Hepatitis Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hepatitis Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Hepatitis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Hepatitis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Hepatitis Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hepatitis Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hepatitis Drugs Market Size by Application (2015-2020)
5.1.1 Global Hepatitis Drugs Sales by Application (2015-2020)
5.1.2 Global Hepatitis Drugs Revenue by Application (2015-2020)
5.1.3 Hepatitis Drugs Price by Application (2015-2020)
5.2 Hepatitis Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Hepatitis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Hepatitis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Hepatitis Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hepatitis Drugs by Country
6.1.1 North America Hepatitis Drugs Sales by Country
6.1.2 North America Hepatitis Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hepatitis Drugs Market Facts & Figures by Type
6.3 North America Hepatitis Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Hepatitis Drugs by Country
7.1.1 Europe Hepatitis Drugs Sales by Country
7.1.2 Europe Hepatitis Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hepatitis Drugs Market Facts & Figures by Type
7.3 Europe Hepatitis Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hepatitis Drugs by Region
8.1.1 Asia Pacific Hepatitis Drugs Sales by Region
8.1.2 Asia Pacific Hepatitis Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hepatitis Drugs Market Facts & Figures by Type
8.3 Asia Pacific Hepatitis Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hepatitis Drugs by Country
9.1.1 Latin America Hepatitis Drugs Sales by Country
9.1.2 Latin America Hepatitis Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hepatitis Drugs Market Facts & Figures by Type
9.3 Central & South America Hepatitis Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis Drugs by Country
10.1.1 Middle East and Africa Hepatitis Drugs Sales by Country
10.1.2 Middle East and Africa Hepatitis Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hepatitis Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Hepatitis Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Description and Business Overview
11.1.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 F. Hoffmann-La Roche Hepatitis Drugs Products Offered
11.1.5 F. Hoffmann-La Roche Related Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Corporation Information
11.2.2 Gilead Sciences Description and Business Overview
11.2.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Gilead Sciences Hepatitis Drugs Products Offered
11.2.5 Gilead Sciences Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Hepatitis Drugs Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Hepatitis Drugs Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Description and Business Overview
11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck Hepatitis Drugs Products Offered
11.5.5 Merck Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Hepatitis Drugs Products Offered
11.6.5 Novartis Related Developments
11.7 Vertex Pharmaceuticals
11.7.1 Vertex Pharmaceuticals Corporation Information
11.7.2 Vertex Pharmaceuticals Description and Business Overview
11.7.3 Vertex Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Vertex Pharmaceuticals Hepatitis Drugs Products Offered
11.7.5 Vertex Pharmaceuticals Related Developments
11.8 Abbvie
11.8.1 Abbvie Corporation Information
11.8.2 Abbvie Description and Business Overview
11.8.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Abbvie Hepatitis Drugs Products Offered
11.8.5 Abbvie Related Developments
11.9 Achillion Pharmaceuticals
11.9.1 Achillion Pharmaceuticals Corporation Information
11.9.2 Achillion Pharmaceuticals Description and Business Overview
11.9.3 Achillion Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Achillion Pharmaceuticals Hepatitis Drugs Products Offered
11.9.5 Achillion Pharmaceuticals Related Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Corporation Information
11.10.2 Bristol-Myers Squibb Description and Business Overview
11.10.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bristol-Myers Squibb Hepatitis Drugs Products Offered
11.10.5 Bristol-Myers Squibb Related Developments
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Description and Business Overview
11.1.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 F. Hoffmann-La Roche Hepatitis Drugs Products Offered
11.1.5 F. Hoffmann-La Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hepatitis Drugs Market Estimates and Projections by Region
12.1.1 Global Hepatitis Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Hepatitis Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Hepatitis Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Hepatitis Drugs Sales Forecast (2021-2026)
12.2.2 North America: Hepatitis Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Hepatitis Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Hepatitis Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Hepatitis Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Hepatitis Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Hepatitis Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hepatitis Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hepatitis Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hepatitis Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hepatitis Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Hepatitis Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Hepatitis Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Hepatitis Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Hepatitis Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hepatitis Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hepatitis Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hepatitis Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hepatitis Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hepatitis Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepatitis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Hepatitis Drugs Market Segments
Table 2. Ranking of Global Top Hepatitis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hepatitis Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of VEMLIDY
Table 5. Major Manufacturers of EPCLUSA
Table 6. Major Manufacturers of SOVALDI
Table 7. Major Manufacturers of INCIVEK
Table 8. Major Manufacturers of OLYSIO
Table 9. Major Manufacturers of VICTRELIS
Table 10. Major Manufacturers of VIREAD
Table 11. Major Manufacturers of HEPSERA
Table 12. Major Manufacturers of BARACLUDE
Table 13. Major Manufacturers of TYZEKA
Table 14. Global Hepatitis Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 15. Global Hepatitis Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 16. Global Hepatitis Drugs Sales by Regions 2015-2020 (K MT)
Table 17. Global Hepatitis Drugs Sales Market Share by Regions (2015-2020)
Table 18. Global Hepatitis Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Hepatitis Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 20. Global Hepatitis Drugs Sales Share by Manufacturers (2015-2020)
Table 21. Global Hepatitis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Hepatitis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis Drugs as of 2019)
Table 23. Hepatitis Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Hepatitis Drugs Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Hepatitis Drugs Price (2015-2020) (USD/MT)
Table 26. Hepatitis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Hepatitis Drugs Product Type
Table 28. Date of International Manufacturers Enter into Hepatitis Drugs Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Hepatitis Drugs Sales by Type (2015-2020) (K MT)
Table 31. Global Hepatitis Drugs Sales Share by Type (2015-2020)
Table 32. Global Hepatitis Drugs Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Hepatitis Drugs Revenue Share by Type (2015-2020)
Table 34. Hepatitis Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 35. Global Hepatitis Drugs Sales by Application (2015-2020) (K MT)
Table 36. Global Hepatitis Drugs Sales Share by Application (2015-2020)
Table 37. North America Hepatitis Drugs Sales by Country (2015-2020) (K MT)
Table 38. North America Hepatitis Drugs Sales Market Share by Country (2015-2020)
Table 39. North America Hepatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Hepatitis Drugs Revenue Market Share by Country (2015-2020)
Table 41. North America Hepatitis Drugs Sales by Type (2015-2020) (K MT)
Table 42. North America Hepatitis Drugs Sales Market Share by Type (2015-2020)
Table 43. North America Hepatitis Drugs Sales by Application (2015-2020) (K MT)
Table 44. North America Hepatitis Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Hepatitis Drugs Sales by Country (2015-2020) (K MT)
Table 46. Europe Hepatitis Drugs Sales Market Share by Country (2015-2020)
Table 47. Europe Hepatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Hepatitis Drugs Revenue Market Share by Country (2015-2020)
Table 49. Europe Hepatitis Drugs Sales by Type (2015-2020) (K MT)
Table 50. Europe Hepatitis Drugs Sales Market Share by Type (2015-2020)
Table 51. Europe Hepatitis Drugs Sales by Application (2015-2020) (K MT)
Table 52. Europe Hepatitis Drugs Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Hepatitis Drugs Sales by Region (2015-2020) (K MT)
Table 54. Asia Pacific Hepatitis Drugs Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Hepatitis Drugs Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Hepatitis Drugs Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Hepatitis Drugs Sales by Type (2015-2020) (K MT)
Table 58. Asia Pacific Hepatitis Drugs Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Hepatitis Drugs Sales by Application (2015-2020) (K MT)
Table 60. Asia Pacific Hepatitis Drugs Sales Market Share by Application (2015-2020)
Table 61. Latin America Hepatitis Drugs Sales by Country (2015-2020) (K MT)
Table 62. Latin America Hepatitis Drugs Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Hepatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Hepatitis Drugs Revenue Market Share by Country (2015-2020)
Table 65. Latin America Hepatitis Drugs Sales by Type (2015-2020) (K MT)
Table 66. Latin America Hepatitis Drugs Sales Market Share by Type (2015-2020)
Table 67. Latin America Hepatitis Drugs Sales by Application (2015-2020) (K MT)
Table 68. Latin America Hepatitis Drugs Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Hepatitis Drugs Sales by Country (2015-2020) (K MT)
Table 70. Middle East and Africa Hepatitis Drugs Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Hepatitis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Hepatitis Drugs Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Hepatitis Drugs Sales by Type (2015-2020) (K MT)
Table 74. Middle East and Africa Hepatitis Drugs Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Hepatitis Drugs Sales by Application (2015-2020) (K MT)
Table 76. Middle East and Africa Hepatitis Drugs Sales Market Share by Application (2015-2020)
Table 77. F. Hoffmann-La Roche Corporation Information
Table 78. F. Hoffmann-La Roche Description and Major Businesses
Table 79. F. Hoffmann-La Roche Hepatitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. F. Hoffmann-La Roche Product
Table 81. F. Hoffmann-La Roche Recent Development
Table 82. Gilead Sciences Corporation Information
Table 83. Gilead Sciences Description and Major Businesses
Table 84. Gilead Sciences Hepatitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Gilead Sciences Product
Table 86. Gilead Sciences Recent Development
Table 87. GlaxoSmithKline Corporation Information
Table 88. GlaxoSmithKline Description and Major Businesses
Table 89. GlaxoSmithKline Hepatitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. GlaxoSmithKline Product
Table 91. GlaxoSmithKline Recent Development
Table 92. Johnson & Johnson Corporation Information
Table 93. Johnson & Johnson Description and Major Businesses
Table 94. Johnson & Johnson Hepatitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Johnson & Johnson Product
Table 96. Johnson & Johnson Recent Development
Table 97. Merck Corporation Information
Table 98. Merck Description and Major Businesses
Table 99. Merck Hepatitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Merck Product
Table 101. Merck Recent Development
Table 102. Novartis Corporation Information
Table 103. Novartis Description and Major Businesses
Table 104. Novartis Hepatitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Novartis Product
Table 106. Novartis Recent Development
Table 107. Vertex Pharmaceuticals Corporation Information
Table 108. Vertex Pharmaceuticals Description and Major Businesses
Table 109. Vertex Pharmaceuticals Hepatitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Vertex Pharmaceuticals Product
Table 111. Vertex Pharmaceuticals Recent Development
Table 112. Abbvie Corporation Information
Table 113. Abbvie Description and Major Businesses
Table 114. Abbvie Hepatitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Abbvie Product
Table 116. Abbvie Recent Development
Table 117. Achillion Pharmaceuticals Corporation Information
Table 118. Achillion Pharmaceuticals Description and Major Businesses
Table 119. Achillion Pharmaceuticals Hepatitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Achillion Pharmaceuticals Product
Table 121. Achillion Pharmaceuticals Recent Development
Table 122. Bristol-Myers Squibb Corporation Information
Table 123. Bristol-Myers Squibb Description and Major Businesses
Table 124. Bristol-Myers Squibb Hepatitis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Bristol-Myers Squibb Product
Table 126. Bristol-Myers Squibb Recent Development
Table 127. Global Hepatitis Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 128. Global Hepatitis Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Hepatitis Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Hepatitis Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Hepatitis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 132. North America: Hepatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Hepatitis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 134. Europe: Hepatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Hepatitis Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 136. Asia Pacific: Hepatitis Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Hepatitis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 138. Latin America: Hepatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Hepatitis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 140. Middle East and Africa: Hepatitis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Hepatitis Drugs Players
Table 145. Hepatitis Drugs Customers List
Table 146. Hepatitis Drugs Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis Drugs Product Picture
Figure 2. Global Hepatitis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. VEMLIDY Product Picture
Figure 4. EPCLUSA Product Picture
Figure 5. SOVALDI Product Picture
Figure 6. INCIVEK Product Picture
Figure 7. OLYSIO Product Picture
Figure 8. VICTRELIS Product Picture
Figure 9. VIREAD Product Picture
Figure 10. HEPSERA Product Picture
Figure 11. BARACLUDE Product Picture
Figure 12. TYZEKA Product Picture
Figure 13. Global Hepatitis Drugs Sales Market Share by Application in 2020 & 2026
Figure 14. Hepatitis A
Figure 15. Hepatitis B
Figure 16. Hepatitis C
Figure 17. Hepatitis D
Figure 18. Hepatitis E
Figure 19. Hepatitis Drugs Report Years Considered
Figure 20. Global Hepatitis Drugs Market Size 2015-2026 (US$ Million)
Figure 21. Global Hepatitis Drugs Sales 2015-2026 (K MT)
Figure 22. Global Hepatitis Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 23. Global Hepatitis Drugs Sales Market Share by Region (2015-2020)
Figure 24. Global Hepatitis Drugs Sales Market Share by Region in 2019
Figure 25. Global Hepatitis Drugs Revenue Market Share by Region (2015-2020)
Figure 26. Global Hepatitis Drugs Revenue Market Share by Region in 2019
Figure 27. Global Hepatitis Drugs Sales Share by Manufacturer in 2019
Figure 28. The Top 10 and 5 Players Market Share by Hepatitis Drugs Revenue in 2019
Figure 29. Hepatitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Hepatitis Drugs Sales Market Share by Type (2015-2020)
Figure 31. Global Hepatitis Drugs Sales Market Share by Type in 2019
Figure 32. Global Hepatitis Drugs Revenue Market Share by Type (2015-2020)
Figure 33. Global Hepatitis Drugs Revenue Market Share by Type in 2019
Figure 34. Global Hepatitis Drugs Market Share by Price Range (2015-2020)
Figure 35. Global Hepatitis Drugs Sales Market Share by Application (2015-2020)
Figure 36. Global Hepatitis Drugs Sales Market Share by Application in 2019
Figure 37. Global Hepatitis Drugs Revenue Market Share by Application (2015-2020)
Figure 38. Global Hepatitis Drugs Revenue Market Share by Application in 2019
Figure 39. North America Hepatitis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 40. North America Hepatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Hepatitis Drugs Sales Market Share by Country in 2019
Figure 42. North America Hepatitis Drugs Revenue Market Share by Country in 2019
Figure 43. U.S. Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 44. U.S. Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Canada Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. North America Hepatitis Drugs Market Share by Type in 2019
Figure 48. North America Hepatitis Drugs Market Share by Application in 2019
Figure 49. Europe Hepatitis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 50. Europe Hepatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Hepatitis Drugs Sales Market Share by Country in 2019
Figure 52. Europe Hepatitis Drugs Revenue Market Share by Country in 2019
Figure 53. Germany Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Germany Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 56. France Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 58. U.K. Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 60. Italy Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. Russia Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Europe Hepatitis Drugs Market Share by Type in 2019
Figure 64. Europe Hepatitis Drugs Market Share by Application in 2019
Figure 65. Asia Pacific Hepatitis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 66. Asia Pacific Hepatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 67. Asia Pacific Hepatitis Drugs Sales Market Share by Region in 2019
Figure 68. Asia Pacific Hepatitis Drugs Revenue Market Share by Region in 2019
Figure 69. China Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. China Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Japan Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Japan Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. South Korea Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. South Korea Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. India Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. India Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Australia Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Australia Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Taiwan Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Taiwan Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Indonesia Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Indonesia Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Thailand Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 84. Thailand Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Malaysia Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 86. Malaysia Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Philippines Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 88. Philippines Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Vietnam Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Vietnam Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Asia Pacific Hepatitis Drugs Market Share by Type in 2019
Figure 92. Asia Pacific Hepatitis Drugs Market Share by Application in 2019
Figure 93. Latin America Hepatitis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 94. Latin America Hepatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 95. Latin America Hepatitis Drugs Sales Market Share by Country in 2019
Figure 96. Latin America Hepatitis Drugs Revenue Market Share by Country in 2019
Figure 97. Mexico Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 98. Mexico Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Brazil Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 100. Brazil Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Argentina Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Argentina Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Latin America Hepatitis Drugs Market Share by Type in 2019
Figure 104. Latin America Hepatitis Drugs Market Share by Application in 2019
Figure 105. Middle East and Africa Hepatitis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 106. Middle East and Africa Hepatitis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 107. Middle East and Africa Hepatitis Drugs Sales Market Share by Country in 2019
Figure 108. Middle East and Africa Hepatitis Drugs Revenue Market Share by Country in 2019
Figure 109. Turkey Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 110. Turkey Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Saudi Arabia Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 112. Saudi Arabia Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 113. U.A.E Hepatitis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 114. U.A.E Hepatitis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 115. Middle East and Africa Hepatitis Drugs Market Share by Type in 2019
Figure 116. Middle East and Africa Hepatitis Drugs Market Share by Application in 2019
Figure 117. North America Hepatitis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. North America Hepatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Hepatitis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Europe Hepatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Hepatitis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Asia Pacific Hepatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Hepatitis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Latin America Hepatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Hepatitis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Middle East and Africa Hepatitis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Hepatitis A Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89

According to our LPI (LP Information) latest study, the global Hepatitis A Vaccine market size was valued at US$ 690.5 million in 2023. With growing demand in downstream market, the Hepatitis A Vaccine is forecast to a readjusted size of US$ 810.9 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Hepatitis A Vaccine market. Hepatitis A Vaccine are expected to show stable growth in the future market. However, produc......

Global Human Hepatitis B Immunoglobulin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Human Hepatitis B Immunoglobulin market: According to our latest research, the global Human Hepatitis B Immunoglobulin market looks promising in the next 5 years. As of 2022, the global Human Hepatitis B Immunoglobulin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......

Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 85

According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at USD 726.3 million in 2023 and is forecast to a readjusted size of USD 842.5 million by 2030 with a CAGR of 2.1% during review period. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currentl......

Global Hepatitis A Vaccine Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 ye......

Global Thymosin a1 Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 103

Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......

Global Thymosin a1 Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 136

Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......

Global Hepatitis B Immune Globulin Market Research Report 2023

Published: 06-Nov-2023        Price: US 2900 Onwards        Pages: 85

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - ADMA Biologics - Bio Products Laboratory - Grifols - Biotest AG - CSL Behring - FFF Enterprises - Cleveland Clinic Seg......

Global Sofosbuvir Market Research Report 2023

Published: 31-Oct-2023        Price: US 2900 Onwards        Pages: 94

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva Pharmaceutical Industries Ltd - DONG BANG FUTURE TECH & LIFE CO., LTD - Beaukev Pharma International Pvt.Ltd - DEAFARMA - Tecoland - Anhui HaiKang Pha......

Global Hepatitis A Vaccine Market Insights, Forecast to 2029

Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 97

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs